ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
24.69
+0.34 (1.40%)
At close: Dec 5, 2025, 4:00 PM EST
24.69
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.02 billion as of December 5, 2025. Its market cap has increased by 11.82% in one year.
Market Cap
1.02B
Enterprise Value
719.03M
1-Year Change
11.82%
Ranking
Category
Stock Price
$24.69
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.02B, an increase of 77.19%. That is a compound annual growth rate of 36.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.01B | 11.98% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |